Atacicept in Multiple Sclerosis Extension Study, Phase II

Clinical trial NCT00853762 · TERMINATED

Trial details

NCT number: NCT00853762
Sponsor: EMD Serono
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2009-03-01
Primary completion: 2009-09-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.